Protalix Biotherapeutics: Detailed Company Information & Corporate Profile

Contact top employees from Protalix Biotherapeutics

Summary

Protalix Biotherapeutics is a public company that has been in the industry for 34 years. The business currently specializes in Biotechnology, Biotechnology areas. Protalix Biotherapeutics's headquarter is located at Carmiel, North District, IL. The number of employees is at least 100. Register with SignalHire to connect with Protalix Biotherapeutics employees and management.

Protalix Biotherapeutics Websiteprotalix.com
Social Links
facebooktwitterlinkedIn
Phone Number972-4-902-8100
Industries
Protalix Biotherapeutics Headquarters address2 Snunit St., Science Park, Carmiel, 2161401 IL
Company Size200-500 employees
SIC Code2836
Founded1994
Estimated Annual Revenue$50M - 100M
Operating StatusIndependent Company

Protalix Biotherapeutics Org Chart

Chief Executive Officer

Chief Executive Officer

phone_icon
email_icon

C-Level

Competitors

Name
Founded
Type
Employees
1979Public
Company
1 - 25
1999Privately
Held
250 - 500
2013Privately
Held
500 - 1.0K
2010Privately
Held
100 - 250

Workforce Turnover

Number of employees switched from or switched to

arrow
Total employee turnover

Departmental sample breakdown

arrow
Turnover activity captured in SignalHire's departmental sample ( employees):

Length of Employment

arrow

Protalix Biotherapeutics's workforce includes employees across a wide range of tenure levels.

9% have been with the company for 1 to 2 years9% have been with the company for 3 to 4 years14% have been with the company for 5 to 7 years14% have been with the company for 8 to 10 years55% have been with the company for more than 11 years

Former Employees: Role Changes

Role at Former Company
Role at New Company
Contact top employees from Protalix Biotherapeutics
Orit Cohen Barak
Orit Cohen BarakHead of Clinical Development
Unlock contacts
Maya Badinter
Maya BadinterQA Coordinator
Unlock contacts
Ronza Sweidan
Ronza SweidanQuality Assurance Coordinator Systems & Laboratories Engineer at Protalix Biotherapeutics
Unlock contacts
Fernando Sallés
Fernando SallésChief Business Officer
Unlock contacts
Moshe Shalit
Moshe ShalitSenior Department Manager of protein purification
Unlock contacts
Orly Niderman Meyer
Orly Niderman MeyerQC Senior Director
Unlock contacts
Peter Vit
Peter VitQP - Chief Pharmacist
Unlock contacts
Radyah Yazbaki
Radyah YazbakiQC Auditor
Unlock contacts
Ron Nativ
Ron NativAnalytical Instrumentation Supervisor
Unlock contacts
Netanel Yehonatan
Netanel YehonatanEngineering Projects Manager
Unlock contacts
Vera Ortish
Vera OrtishQuality Assurance Specialist
Unlock contacts
Liana Younis
Liana YounisBioanalyst
Unlock contacts
Yakop Saed
Yakop SaedResearch Assistant
Unlock contacts
Mohamed Awawdy
Mohamed AwawdySystem Validation Engineer
Unlock contacts
RENATA BARATA
RENATA BARATAKey Account Manager - Iqvia
Unlock contacts
Nathalia Alencar Teixeira
Nathalia Alencar TeixeiraKey Account Manager
Unlock contacts

Protalix Biotherapeutics Corporate Information: FAQ

Protalix Biotherapeutics operates in the Biotech industries. More details can be found on the official website: protalix.com.
Protalix Biotherapeutics has offices located in Carmiel, IL.
The headquarters of Protalix Biotherapeutics are located in Carmiel, Israel.
The current CEO of Protalix Biotherapeutics is Dror Bashan
You can contact Protalix Biotherapeutics by phone at 972-4-902-8100.
Protalix Biotherapeutics currently employs 200-500 people.
Well-known competitors of Protalix Biotherapeutics include Dyadic Applied BioSolutions, Medicago, Alvotech and Batavia Biosciences.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP